Page last updated: 2024-08-23

lovastatin and Osteosarcoma

lovastatin has been researched along with Osteosarcoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's1 (11.11)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Cappellini, A; Chiarini, F; Evangelisti, C; Faenza, I; Giuntini, G; Lattanzi, G; Maltarello, MC; Martelli, AM; Mattioli, E; Paganelli, F; Ramazzotti, G; Scotlandi, K1
Beutler, JA; Goetz, M; Goncharova, EI; Hao, X; Henrich, CJ; Huang, S; Jia, L; Kambala, A; Khanna, C; LeBlanc, A; Long, SA; Ren, L; Wilson, J; Yang, X1
Chen, J; Huang, Y; Jin, M; Liu, J; Shao, H; Zhang, J; Zhao, H1
Fritz, G; Huelsenbeck, J; Nilsson, S1
Brion, R; Ebetion, FH; Heymann, D; Moriceau, G; Redini, F; Roelofs, AJ; Rogers, MJ1
Miller, AC; Samid, D1
Clark, EP; Gafner, J; Miller, AC; Samid, D1
Clark, EP; Kariko, K; Miller, AC; Myers, CE; Samid, D1
Abe, K; Asami, S; Kodama, T; Konishi, K; Oikawa, S; Sugiyama, M1

Other Studies

9 other study(ies) available for lovastatin and Osteosarcoma

ArticleYear
Lamin A and Prelamin A Counteract Migration of Osteosarcoma Cells.
    Cells, 2020, 03-22, Volume: 9, Issue:3

    Topics: Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lamin Type A; Lovastatin; Osteoblasts; Osteosarcoma

2020
Identification of potential modulators of osteosarcoma metastasis by high-throughput cellular screening of natural products.
    Chemical biology & drug design, 2021, Volume: 97, Issue:1

    Topics: Biological Products; Bone Neoplasms; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Drugs, Chinese Herbal; High-Throughput Screening Assays; Humans; Lovastatin; Melia; Monascus; Osteosarcoma; Plant Extracts; Pyridines; Seeds

2021
miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 51, Issue:2

    Topics: 3' Untranslated Regions; Antagomirs; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cysteine-Rich Protein 61; Epithelial-Mesenchymal Transition; Humans; Lovastatin; MicroRNAs; Osteosarcoma; RNA Interference; RNA, Small Interfering; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Up-Regulation

2018
Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
    Cancer letters, 2011, May-01, Volume: 304, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Proliferation; Cisplatin; Diphosphonates; DNA Damage; Doxorubicin; Fibrosarcoma; Humans; Lovastatin; Metformin; Mevalonic Acid; Osteosarcoma; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2011
Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
    Cancer, 2012, Feb-01, Volume: 118, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Proliferation; Diphosphonates; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Protein Prenylation; Rats; Tumor Cells, Cultured

2012
Tumor resistance to oxidative stress: association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21ras isoprenylation.
    International journal of cancer, 1995, Jan-17, Volume: 60, Issue:2

    Topics: Doxorubicin; gamma-Glutamyltransferase; Genes, ras; Humans; Lovastatin; Osteosarcoma; Oxidative Stress; Protein Prenylation; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Tumor Cells, Cultured

1995
Differences in radiation-induced micronuclei yields of human cells: influence of ras gene expression and protein localization.
    International journal of radiation biology, 1993, Volume: 64, Issue:5

    Topics: Cell Line; Genes, ras; Humans; Lovastatin; Micronucleus Tests; Osteosarcoma; Radiation Genetics

1993
Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation.
    International journal of cancer, 1993, Jan-21, Volume: 53, Issue:2

    Topics: Animals; Cell Cycle; Cell Line, Transformed; Female; Genes, ras; Humans; Lovastatin; Mice; Mice, Nude; Neoplasm Transplantation; Osteosarcoma; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Radiation Tolerance; Tumor Cells, Cultured

1993
Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
    Biochemical and biophysical research communications, 2000, May-19, Volume: 271, Issue:3

    Topics: Anti-Bacterial Agents; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Bone Neoplasms; Cloning, Molecular; Disulfides; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Indole Alkaloids; Lovastatin; Mevalonic Acid; Osteoporosis; Osteosarcoma; Pravastatin; Promoter Regions, Genetic; RNA, Messenger; Simvastatin; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured

2000